Yuchun Lee, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,183 shares at $267.23 ($1.9M) on 2022-04-04, disclosed to the SEC on 2022-04-06.
Open-market sale of $1.9M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $265.83 | 100 | $27K | 1.4% |
| 2 | $267.23 | 917 | $245K | 12.6% |
| 3 | $267.23 | 917 | $245K | 12.6% |
| 4 | $268.36 | 983 | $264K | 13.6% |
| 5 | $268.36 | 983 | $264K | 13.6% |
| 6 | $268.30 | 17 |
| $5K |
| 0.2% |
| 7 | $270.05 | 334 | $90K | 4.7% |
| 8 | $270.05 | 334 | $90K | 4.7% |
| 9 | $271.94 | 488 | $133K | 6.8% |
| 10 | $271.94 | 488 | $133K | 6.8% |
| 11 | $272.60 | 600 | $164K | 8.4% |
| 12 | $273.50 | 100 | $27K | 1.4% |
| 13 | $274.66 | 461 | $127K | 6.5% |
| 14 | $274.66 | 461 | $127K | 6.5% |
| Total | $269.91 avg | 7,183 | $1.9M | 100% |
| Filing → |
| VRTX | SELL | 2023-01-25 | $3.8M | — | Filing → |
| VRTX | SELL | 2023-01-19 | $1.5M | — | Filing → |
| VRTX | SELL | 2022-04-20 | $1.1M | — | Filing → |